Browsing by Subject Breast cancer

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 360 to 379 of 438 < previous   next >
Issue DateTitleAuthor(s)
28-Sep-2022Safety and efficacy of ribociclib plus letrozole in patients with HR+, HER2– advanced breast cancer: Results from the Spanish sub-population of the phase 3b CompLEEment-1 trialSalvador Bofill, Javier; Moreno Anton, Fernando; Rodríguez Sánchez, César A.; Galve Calvo, Elena; Hernando Melia, Cristina; Ciruelos Gil, Eva Maria; Vidal Losada, Maria Jesús; Jiménez Rodriguez, Begoña; De La Cruz Merino, Luis; Martínez Jañez, Noelia; Villanueva Vazquez, Rafael; De Toro Salas, Ruben; Anton Torres, Antonio; Alvarez Lopez, Isabel Manuela; Gavila Gregori, Joaquin; Quiroga Garcia, Vanesa; Vicente Rubio, Elena; De La Haba Rodriguez, Juan; Gonzalez Santiago, Santiago; Diaz Fernandez, Nieves; Barnadas Molins, Agusti; Cantos Sanchez De Ibargüen, Blanca; Delgado Mingorance, Juan Ignacio; Bellet Ezquerra, Meritxell; De Casa, Sonia; Gimeno, Asuncion; Martin, Miguel
19-Aug-2022Safety and immunogenicity of the COVID-19 vaccine BNT162b2 for patients with breast and gynecological cancer on active anticancer therapy: Results of a prospective observational studyPlacido, Pietro De; Pietroluongo, Erica; Angelis, Carmine De; Tafuro, Margherita; Barraco, Chiara; Giannatiempo, Rosa; Buonaiuto, Roberto; Schettini, Francesco; Iervolino, Anna; Vozzella, Emilia Anna; Giuliano, Mario; Bianco, Roberto; Arpino, Grazia
9-Jan-2019Safety, activity, and molecular heterogeneity following neoadjuvant non-pegylated liposomal doxorubicin, paclitaxel, trastuzumab, and pertuzumab in HER2-positive breast cancer (Opti-HER HEART): an open-label, single-group, multicenter, phase 2 trialGavilá, Joaquín; Oliveira, Mafalda; Pascual, Tomás; Perez-Garcia, Jose; Gonzàlez, Xavier; Canes, Jordi; Paré, Laia; Calvo Serrano, Isabel; Ciruelos, Eva; Muñoz Mateu, Montserrat; Virizuela, Juan A.; Ruiz, Isabel; Andrés, Raquel; Perelló, Antonia; Martínez, Jerónimo; Morales, Serafín; Marín Aguilera, Mercedes; Martínez, Debora; Quero, Juan C.; Llombart-Cussac, Antonio; Prat Aparicio, Aleix
1-Apr-2019Second breast-conserving therapy with interstitial brachytherapy (APBI) as a salvage treatment in ipsilateral breast tumor recurrence: a retrospective study of 40 patientsCozzi, Salvatore; Jamal, Dina Najjari; Slocker, Andrea; Laplana, Maria; García-Tejedor, Amparo; Krengli, Marco; Guedea Edo, Ferran; Gutiérrez Miguélez, Cristina
25-Oct-2011Selective inhibition of microRNA accessibility by RBM38 is required for p53 activityLéveillé, Nicolas; Elkon, Ran; Davalos, Veronica; Manoharan, Vijayalaxmi; Hollingworth, Dave; Vrielink, Joachim Oude; Le Sage, Carlos; Melo, Carlos A.; Horlings, Hugo M.; Wesseling, Jelle; Ule, Jernej; Esteller, Manel; Ramos, Andres; Agami, Reuven
2023Self-assessment of a breast care nursing model within a Breast Unit: learning process and keys to improving breast careRodriguez-Ortega, Ana; Ferro, Tàrsila; Pérez, Xavier; Pla Farnós, María Jesús; Gil Gil, Miguel; López Ojeda, Anna; Borràs Andrés, Josep Maria
1-Sep-2018Serum 25-hydroxyvitamin D and breast cancer risk by pathological subtype (MCC-Spain)Lope, Virginia; Castelló, Adela; Mena Bravo, Antonio; Amiano, Pilar; Aragonès Sanz, Núria; Fernández Villa, Tania; Guevara, Marcela; Dierssen Sotos, Trinidad; Fernandez Tardón, Guillermo; Castaño-Vinyals, Gemma; Marcos Gragera, Rafael; Moreno Aguado, Víctor; Salas Trejo, María Dolores; Díaz Santos, Marian; Oribe, Madalen; Romieu, Isabelle; Kogevinas, Manolis; Priego Capote, Feliciano; Pérez Gómez, Beatriz; Pollán, Marina
1-Oct-2020Serum Phospholipids Fatty Acids and Breast Cancer Risk by Pathological SubtypeLope, Virginia; Guerrero Zotano, Ángel; Casas, Ana; Baena Cañada, José Manuel; Bermejo, Begona; Pérez Gómez, Beatriz; Criado Navarro, Inmaculada; Antolín, Silvia; Sánchez Rovira, Pedro; Ramos Vázquez, Manuel; Antón, Antonio; Castelló, Adela; García Saenz, Jose Angel; Muñoz Mateu, Montserrat; Juan, Ana de; Andrés, Raquel; Llombart Cussac, Antonio; Hernando, Blanca; Franquesa, Rosa María; Caballero, Rosalía; Priego Capote, Feliciano; Martón, Miguel; Pollán, Marina
7-Jun-2022Sexual function in breast cancer patients: A Review of the literatureCastillo Ecija, Helena; Mension, Eduard; Cebrecos, Isaac; Anglès Acedo, Sònia; Castelo-Branco Flores, Camil
7-Jun-2019Significant Clinical Activity of Olaparib in a Somatic BRCA1-Mutated Triple-Negative Breast Cancer With Brain MetastasisPascual, Tomás; González Farré, Blanca; Teixidó, Cristina; Oleaga Zufiría, Laura; Oses, Gabriela; Ganau, Sergi; Chic, Núria; Riu Viladoms, Gisela; Adamo, Barbara; Galván, Patricia; Vidal Losada, Maria Jesús; Soy Muner, Dolors; Urbano Ispizua, Álvaro; Muñoz Mateu, Montserrat; Prat Aparicio, Aleix
26-Sep-2016Silencing of CD47 and SIRPα by Polypurine reverse Hoogsteen hairpins to promote MCF-7 breast cancer cells death by PMAdifferentiated THP-1 cellsBener, Gizem; Félix, Álex J.; Sánchez de Diego, Cristina; Pascual Fabregat, Isabel; Ciudad i Gómez, Carlos Julián; Noé Mata, Verónica
5-Feb-2016Síndrome de cáncer de mama y ovario hereditario: Estudio in vitro de variantes BRCA1 y BRCA2 de significado biológico desconocido y búsqueda de nuevos genes responsables de este síndromeQuiles Vidal, Francisco de Asís
16-Dec-2022Sleep and breast and prostate cancer risk in the MCC-Spain studyTurner, Michelle C.; Gracia Lavedan, Esther; Papantoniou, Kyriaki; Aragonés, Nuria; Castaño Vinyals, Gemma; Dierssen Sotos, Trinidad; Amiano, Pilar; Ardanaz, Eva; Marcos Delgado, Alba; Molina Barceló, Ana; Alguacil, Juan; Benavente, Yolanda; Belmonte, Thalia; Jiménez Moleón, José Juan; Marcos Gragera, Rafael; Pérez, Beatriz; Gómez Acebo, Inés; Pollán, Marina; Kogevinas, Manolis
30-Nov-2023Smoking history and breast cancer risk by pathological subtype: MCC-Spain studyPeñalver Argüeso, Belén; García Esquinas, Esther; Castelló, Adela; Fernández de Larrea Baz, Nerea; Castaño Vinyals, Gemma; Amiano, Pilar; Fernández Villa, Tania; Guevara, Marcela; Fernández Tardón, Guillermo; Alguacil, Juan; Obón Santacana, Mireia; Gómez Acebo, Inés; Pinto Carbó, Marina; Marcos Gragera, Rafael; Aragonés, Nuria; Aizpurua, Amaia; Martín Sánchez, Vicente; Ardanaz, Eva; Dierssen Sotos, Trinidad; Jiménez Moleón, Jose Juan; Kogevinas, Manolis; Pollán, Marina; Pérez Gómez, Beatriz
23-Apr-2021SOLTI-1805 TOT-HER3 Study Concept: A Window-of-Opportunity Trial of Patritumab Deruxtecan, a HER3 Directed Antibody Drug Conjugate, in Patients With Early Breast CancerPascual, Tomás; Oliveira, Mafalda; Ciruelos, Eva; Bellet Ezquerra, Meritxell; Saura, Cristina; Gavilá, Joaquin; Pernas, Sònia; Muñoz Mateu, Montserrat; Vidal Losada, Maria Jesús; Margelí Vila, Mireia; Cejalvo Andújar, Juan Miguel; González Farré, Blanca; Espinosa Bravo, Martin; Cruz, Josefina; Salvador Bofill, Francisco Javier; Guerra, Juan Antonio; Luna Barrera, Ana María; Arumi de Dios, Miriam; Esker, Stephen; Fan, Pang-dian; Martínez Sáez, Olga; Villacampa, Guillermo; Paré, Laia; Ferrero Cafiero, Juan M.; Villagrasa, Patricia; Prat Aparicio, Aleix
27-Mar-2017Stepwise analysis of MIR9 loci identifies miR-9-5p to be involved in Oestrogen regulated pathways in breast cancer patientsBarbano, Raffaela; Pasculli, Barbara; Rendina, Michelina; Fontana, Andrea; Fusilli, Caterina; Copetti, Massimiliano; Castellana, Stefano; Valori, Vanna Maria; Morritti, Maria; Graziano, Paolo; Luigi, Ciuffreda; Coco, Michelina; Picardo, Francesco; Mazza, Tommaso; Evron, Ella; Murgo, Roberto; Maiello, Evaristo; Esteller, Manel; Fazio, Vito Michele; Parrella, Paola
24-Aug-2016Stratification and therapeutic potential of PML in metastatic breast cancerMartín-Martín, Natalia; Piva, Marco; Urosevic, Jelena; Aldaz, Paula; Sutherland, James David; Fernández-Ruiz, Sonia; Arreal, Leire; Torrano, Verónica; Cortazar, Ana Rosa; Planet, Evarist; Guiu, Marc; Radosevic Robin, Nina; Garcia, Stephane; Macías, Iratxe; Salvador, Fernando; Domenici, Giacomo; Rueda, Oscar M.; Zabala Letona, Amaia; Arruabarrena-Aristorena, Amaia; Zúñiga García, Patricia; Caro Maldonado, Alfredo; Valcarcel-Jimenez, Lorea; Sánchez Mosquera, Pilar; Varela Rey, Marta; Martínez Chantar, Maria Luz; Anguita, Juan; Ibrahim, Yasir H.; Scaltriti, Maurizio; Lawrie, Charles H.; Aransay, Ana M.; Iovanna, Juan L.; Baselga Torres, Josep, 1959-; Caldas, Carlos; Barrio, Rosa; Serra, Violeta; Vivanco, Maria d. M.; Matheu, Ander; Gomis i Cabré, Roger; Carracedo, Arkaitz
22-Feb-2022Stromal Oncostatin M cytokine promotes breast cancer progression by reprogramming the tumour microenvironmentAraujo, Ángela M.; Abaurrea, Andrea; Azcoaga, Peio; López Velazco, Joanna I.; Manzano, Sara; Rodríguez, Javier; Rezola, Ricardo; Egia Mendikute, Leire; Valdés Mora, Fátima; Flores, Juana M.; Jenkins, Liam; Pulido, Laura; Osorio Querejeta, Iñaki; Fernandez-Nogueira, Patricia; Ferrari, Nicola; Viera, Cristina; Martin Martin, Natalia; Tzankov, Alexandar; Eppenberger Castori, Serenella; Alvarez Lopez, Isabel Manuela; Urruticoechea Ribate, Ander; Bragado Domingo, Paloma; Coleman, Nicholas; Palazón, Asis; Carracedo, Arkaitz; Gallego Ortega, David; Calvo, Fernando; Isacke, Clare M.; Caffarel, María M.; Lawrie, Charles H.
Nov-2013Substance P autocrine signaling contributes to persistent HER2 activation that drives malignant progression and drug resistance in breast cancer.Garcia Recio, Susana; Fuster Orellana, Gemma; Fernandez-Nogueira, Patricia; Pastor Arroyo, Eva M.; Yeong Park, So; Mayordomo, Cristina; Ametller, Elisabet; Mancino, Mario; Gonzalez-Farre, Xavier; Russnes, Hage G.; Engel Rocamora, Pablo; Costamagna, Domiziana; Fernandez, Pedro L.; Gascón, Pere; Almendro Navarro, Vanessa
1-Nov-2010Supervivencia a los cinco años de las mujeres diagnosticadas de cáncer de mama durante el periodo 1997-1999 en el área de Toledo centro y ManchaGarcía Rodríguez, José; García Colmenero, Carmen; Clèries Soler, Ramon; Oleaga Sancho, Isabel